Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)
0.2681
-0.0134
(-4.76%)
Streaming Delayed Price
Updated: 3:44 PM EDT, Apr 14, 2026
Add to My Watchlist
All News about Calidi Biotherapeutics, Inc. Common Stock
Scientists Discover Why Immunotherapy Frequently Fails
February 04, 2026
Major Discovery Could Reshape Cancer Immunotherapy
March 27, 2026
Oncolytic Virus Therapy is Set to Transform Cancer Care
March 20, 2026
Unusual volume stocks in Tuesday's session ↗
March 10, 2026
Cancer Stress Protein Enables Tumors to Evade the Immune System
February 20, 2026
Existing Cancer Drug Shows Potential in Reactivating Immunotherapy
February 17, 2026
Early Symptoms of Lung Cancer You Could Be Ignoring
February 12, 2026
Novel Therapy Helps Tumor Cells Welcome Cancer Treatment
January 28, 2026
New Approach Could Increase Response Rates for Cancer Immunotherapy
December 23, 2025
Novel Biomarker Could Predict Resistance to Immunotherapy, Study Finds
December 17, 2025
Study Highlights Increasing Cases of Breast Cancer in Younger Women
December 12, 2025
Study Proposes Overhaul of US Lung Cancer Screening Guidelines
December 08, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube